Teva Branded Pharmaceutical Products R&D
Teva Branded Pharmaceutical Products R&D is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase 2b, Randomized, Double-Blind Long-Term Extension Study to Evaluate Pharmacokinetics, Efficacy, Safety, and Tolerability of TEV-48574 in Adult Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease who completed the treatment phase of the Dose-Ranging Study (RELIEVE UCCD LTE)
Sponsor Teva Branded Pharmaceutical Products R&D LLC
- Start (EU)
- Latest update
- Estimated end
A Multicenter, Open-Label Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Pediatric Patients 6 to 17 Years of Age
Sponsor Teva Branded Pharmaceutical Products R&D LLC
- Start (EU)
- Latest update
- Estimated end
A 14-Week Phase 2b, RandomizEd, Double-BLind, Dose-Ranging Study to Determine the PharmacokInetics, Efficacy, Safety, and Tolerability of TEV-48574 in Adult PatiEnts with Moderate to Severe Ulcerative Colitis or Crohn’s Disease (RELIEVE UCCD)
Sponsor Teva Branded Pharmaceutical Products R&D Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Teva Branded Pharmaceutical Products R&D?
The 2026-10-09 snapshot links Teva Branded Pharmaceutical Products R&D to 3 distinct CTIS trials. Recorded services include Laboratory services, Analysis of TL1A tissue biomarker samples, Bioanalytical Pharmacokinetics Evaluation, Bioanalytical Immunogenicity Evaluation, Other - PK and ADA analysis, among 5 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Teva Branded Pharmaceutical Products R&D?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Teva Branded Pharmaceutical Products R&D conducted?
The linked trials record locations in 14 countries, including Germany, Spain, Italy, Poland, Austria. These are trial locations, not confirmed office locations or countries where Teva Branded Pharmaceutical Products R&D delivered services.
What can this page tell me about Teva Branded Pharmaceutical Products R&D's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under Teva Branded Pharmaceutical Products R&D. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Teva Branded Pharmaceutical Products R&D Inc.
- Teva Branded Pharmaceutical Products R&D LLC